Abstract:Healthy women at reproductive age experience a cyclical alteration of gastrointestinal (GI) symptomatology during their menstrual cycle. Additionally, the majority of healthy women also complain of worsening of GI symptoms either during the premenstrual or menstrual phase. Despite conflicting evidence, studies suggest that sex hormones may increase GI transit time during the luteal phase. Similar phenomenon is also observed in women with underlying inflammatory bowel disease (IBD). The mechanism underlying this complex pathophysiology is still not completely understood. However, a possible influence of sex hormones on the brain-gut-microbiota axis is hypothesized. The diagnosis of IBD is associated with a delay in menarche as well as menstrual function irregularities including alterations in cycle length and the duration of flow. There is little data on the effect of menopause on IBD disease activity and conflicting data on the effect of IBD diagnosis on the onset of menopause. The role of contraceptives and hormone replacement therapies on the development or disease activity of IBD has not been yet established. Moreover, IBD patients with concomitant dysmenorrhea report heightened pain during menses. The effect of non-steroidal anti-inflammatory drugs in treating primary dysmenorrhea on the disease course of IBD is unknown. In addition, the effect of IBD medications including immunomodulators and biologics on menstrual function remains unclear. Also, the role of IBD surgery on menstrual irregularities needs to be fully elucidated. Hence, understanding the influence of menstrual function on IBD disease activity and vice versa and the maintenance of normal menstrual function in those patients is important in improving overall reproductive health and fertility and outcome of IBD.

S783 Exploring the Gender-Specific Impact of Hormonal Factors on GI Motility Disorders: A Comprehensive Population-Based Study

S2311 The Association Between Hormone Replacement Therapy and Gastric Motility Disorders in Post-Menopausal Women

Upper Gastrointestinal Tract Motility Disorders in Women, Gastroparesis, and Gastroesophageal Reflux Disease

Sex-Gender Differences in Irritable Bowel Syndrome

Prevalence and Risk Factors for Functional Bowel Disorders in South China: a Population Based Study Using the Rome III Criteria.

Prevalence and predictors of small intestinal bacterial overgrowth in irritable bowel syndrome: a systematic review and meta-analysis

Prevalence of Irritable Bowel Syndrome among Undergraduates in Southeast China

Su1632 Evaluation of Prokinetic Drugs on Gastric Emptying of Solid in Patients with Postprandial Distress Syndrome

Gender differences in gastrointestinal, biopsychosocial and healthcare-seeking behaviors in Chinese patients with irritable bowel syndrome predominant with diarrhea

Gender-specific insights into the irritable bowel syndrome pathophysiology. Focus on gut dysbiosis and permeability

Impact of Gender on Gastroesophageal Reflux Disease Complications: Analysis of 27 Million Hospitalizations

[Gender medicine in diseases of the upper gastrointestinal tract]

Gender-related differences in IBS symptoms

S762 Sex-Based Differences in Outpatients With Irritable Bowel Syndrome at a Large Safety Net Hospital

Gender Differences in Serotonin Signaling in Patients with Diarrhea-predominant Irritable Bowel Syndrome

The Gut Microbiome and Sex Hormone-Related Diseases

Menstrual cycle, sex hormones in female inflammatory bowel disease patients with and without surgery

Sex- and gender-related differences in the prevalence and burden of disorders of gut-brain interaction in Poland

Gut microbiota and female health

Sex-based Differences in Fecal Short-Chain Fatty Acid and Gut Microbiota in Irritable Bowel Syndrome Patients

Menstrual and Reproductive Factors and Gastric Cancer Risk in A Large Prospective Study of Women